OBJECTIVE: Rheumatoid arthritis (RA) is a chronic inflammatory disease which involves the synovial membrane of multiple diarthroidal joints causing damage to cartilage and bones. The damage process seems to be related to an overproduction of oxygen reactive species inducing an oxidative perturbation. Since sulfhydryl groups are primary antioxidant factors, we were interested in investigating the balance of plasma sulfhydryl/disulfides in patients with active RA compared to healthy control subjects. METHODS: Twenty-one patients with RA and 15 age-matched controls were studied. Plasmatic sulfhydryl groups and their disulfide form concentrations were measured by spectrophotometry or HPLC. RESULTS: RA patients showed significantly lower levels of plasma protein sulfhydryls and cysteinyl-glycine compared to healthy controls (p < 0.001). Conversely, cystine and homocystine, and protein-bound cysteine and homocysteine were significantly increased (p < 0.005 in disulfides forms and p < 0.05 in protein mixed disulfides forms). There was a significant correlation between some clinical data (ESR, number of tender/swollen joints) and some of the parameters studied. CONCLUSION: The results of this study indicate a biochemical disturbance of plasma sulfhydryl/disulfides balance in patients with RA compared to controls with an increase in some oxidised forms (disulfides and protein mixed disulfides) and a decrease in free thiols. The increase in total homocysteine, correlated to the higher risk of cardiovascular diseases in RA patients, is associated with higher levels of the oxidised forms, disulfides and protein-thiol mixed disulfides.
OBJECTIVE:Rheumatoid arthritis (RA) is a chronic inflammatory disease which involves the synovial membrane of multiple diarthroidal joints causing damage to cartilage and bones. The damage process seems to be related to an overproduction of oxygen reactive species inducing an oxidative perturbation. Since sulfhydryl groups are primary antioxidant factors, we were interested in investigating the balance of plasma sulfhydryl/disulfides in patients with active RA compared to healthy control subjects. METHODS: Twenty-one patients with RA and 15 age-matched controls were studied. Plasmatic sulfhydryl groups and their disulfide form concentrations were measured by spectrophotometry or HPLC. RESULTS:RApatients showed significantly lower levels of plasma protein sulfhydryls and cysteinyl-glycine compared to healthy controls (p < 0.001). Conversely, cystine and homocystine, and protein-bound cysteine and homocysteine were significantly increased (p < 0.005 in disulfides forms and p < 0.05 in protein mixed disulfides forms). There was a significant correlation between some clinical data (ESR, number of tender/swollen joints) and some of the parameters studied. CONCLUSION: The results of this study indicate a biochemical disturbance of plasma sulfhydryl/disulfides balance in patients with RA compared to controls with an increase in some oxidised forms (disulfides and protein mixed disulfides) and a decrease in free thiols. The increase in total homocysteine, correlated to the higher risk of cardiovascular diseases in RApatients, is associated with higher levels of the oxidised forms, disulfides and protein-thiol mixed disulfides.
Authors: Alejandro Villasante; Oscar F Araneda; Claus Behn; Marco Galleguillos; Hector Adarmes Journal: Vet Res Commun Date: 2009-12-12 Impact factor: 2.459
Authors: L Gallego-Villar; Luciana Hannibal; J Häberle; B Thöny; T Ben-Omran; G K Nasrallah; Al-N Dewik; W D Kruger; H J Blom Journal: J Inherit Metab Dis Date: 2017-06-22 Impact factor: 4.982
Authors: Ewa Aleksandra Rodziewicz-Flis; Małgorzata Kawa; Damian Józef Flis; Marzena Szaro-Truchan; Wojciech Romuald Skrobot; Jan Jacek Kaczor Journal: Front Physiol Date: 2022-04-20 Impact factor: 4.755
Authors: Paolo Fanti; Daniela Giustarini; Ranieri Rossi; Sue E D Cunningham; Franco Folli; Khaled Khazim; John Cornell; Elena Matteucci; Shweta Bansal Journal: J Ren Nutr Date: 2015-07-31 Impact factor: 3.655
Authors: Bridget Fox; Jan-Thorsten Schantz; Richard Haigh; Mark E Wood; Phillip K Moore; Nick Viner; Jeremy P E Spencer; Paul G Winyard; Matthew Whiteman Journal: J Cell Mol Med Date: 2012-04 Impact factor: 5.310
Authors: Arno R Bourgonje; Ruben Y Gabriëls; Martin H de Borst; Marian L C Bulthuis; Klaas Nico Faber; Harry van Goor; Gerard Dijkstra Journal: Antioxidants (Basel) Date: 2019-09-01